FONAR Co. (NASDAQ:FONR - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $14.39 and traded as high as $14.98. FONAR shares last traded at $14.51, with a volume of 22,208 shares trading hands.
Analyst Ratings Changes
Separately, Wall Street Zen upgraded shares of FONAR from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 19th.
Check Out Our Latest Research Report on FONR
FONAR Stock Up 0.3%
The stock's 50 day moving average price is $13.13 and its 200-day moving average price is $14.35. The stock has a market capitalization of $90.25 million, a P/E ratio of 12.65 and a beta of 0.99.
FONAR (NASDAQ:FONR - Get Free Report) last released its quarterly earnings data on Thursday, May 15th. The medical equipment provider reported $0.37 earnings per share (EPS) for the quarter. FONAR had a net margin of 7.68% and a return on equity of 4.94%.
Institutional Investors Weigh In On FONAR
Several institutional investors have recently bought and sold shares of FONR. Truffle Hound Capital LLC acquired a new stake in FONAR in the fourth quarter valued at approximately $1,363,000. Linden Thomas Advisory Services LLC boosted its stake in FONAR by 16.5% in the first quarter. Linden Thomas Advisory Services LLC now owns 34,054 shares of the medical equipment provider's stock valued at $477,000 after acquiring an additional 4,818 shares in the last quarter. Money Concepts Capital Corp boosted its stake in FONAR by 1.2% in the first quarter. Money Concepts Capital Corp now owns 406,296 shares of the medical equipment provider's stock valued at $5,692,000 after acquiring an additional 4,719 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in FONAR by 0.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 376,678 shares of the medical equipment provider's stock valued at $5,703,000 after acquiring an additional 2,149 shares in the last quarter. Finally, Empowered Funds LLC boosted its stake in FONAR by 7.7% in the first quarter. Empowered Funds LLC now owns 21,139 shares of the medical equipment provider's stock valued at $296,000 after acquiring an additional 1,504 shares in the last quarter. 50.64% of the stock is currently owned by institutional investors and hedge funds.
FONAR Company Profile
(
Get Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Featured Stories
Before you consider Fonar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fonar wasn't on the list.
While Fonar currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
